Beta Drugs Limited — Board Meeting, 09-01-2026: Outcome of Board Meeting

Beta Drugs' board greenlit acquiring 66.09% of Nivian Life Sciences (IVF products) for ~69.40 Cr (cash + shares). Nivian had FY25 turnover of 29.12 Cr. Also approved raising authorized capital to 11.40 Cr and an ESOP for 2 lakh options. An EGM on February 4, 2026, seeks shareholder nod for these moves.